Report Summary
Eternity Insights has published a new study on Global Targeted RNA Sequencing Market focusing on key segments as by Type (Qualitative Targeted RNA Sequencing,Quantitative Targeted RNA Sequencing, Other), by Application (Research Institutes,Hospitals & Clinics,Biotechnology Company,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Targeted RNA Sequencing Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Targeted RNA Sequencing Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Targeted RNA Sequencing Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Targeted RNA Sequencing Market Segmentation:
Targeted RNA Sequencing Market, By Type
- Qualitative Targeted RNA Sequencing
- Quantitative Targeted RNA Sequencing
- Other
Targeted RNA Sequencing Market, By Application
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Targeted RNA Sequencing market in terms of demand generation. The Targeted RNA Sequencing market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Targeted RNA Sequencing market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Targeted RNA Sequencing Market Taxonomy:
To learn more about this report
Global Targeted RNA Sequencing Market Competitive Landscape
The global Targeted RNA Sequencing market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Qualitative Targeted RNA Sequencing,Quantitative Targeted RNA Sequencing, Other |
| By Application Outlook |
Research Institutes,Hospitals & Clinics,Biotechnology Company,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Thermo Fisher,Illumina,Roche Holdings,BGI,Eurofins,LabCorp,Berry Genomics,Macrogen,GENEWIZ |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Targeted RNA Sequencing Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Targeted RNA Sequencing Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Targeted RNA Sequencing Market Performance
2.3 USA Targeted RNA Sequencing Market Performance
2.4 Europe Targeted RNA Sequencing Market Performance
2.5 Japan Targeted RNA Sequencing Market Performance
2.6 Korea Targeted RNA Sequencing Market Performance
2.7 India Targeted RNA Sequencing Market Performance
2.8 Southeast Asia Targeted RNA Sequencing Market Performance
2.9 South America Targeted RNA Sequencing Market Performance
3 Global Targeted RNA Sequencing Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Targeted RNA Sequencing Market Performance (Volume)
3.3 USA Targeted RNA Sequencing Market Performance (Volume)
3.4 Europe Targeted RNA Sequencing Market Performance (Volume)
3.5 Japan Targeted RNA Sequencing Market Performance (Volume)
3.6 Korea Targeted RNA Sequencing Market Performance (Volume)
3.7 India Targeted RNA Sequencing Market Performance (Volume)
3.8 Southeast Asia Targeted RNA Sequencing Market Performance (Volume)
3.9 South America Targeted RNA Sequencing Market Performance (Volume)
4 Competitive Analysis
4.1 Thermo Fisher
4.1.1 Thermo Fisher Profiles
4.1.2 Thermo Fisher Product Information
4.1.3 Thermo Fisher Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.1.4 Thermo Fisher Targeted RNA Sequencing Business Performance
4.1.5 SWOT Analysis
4.2 Illumina
4.2.1 Illumina Profiles
4.2.2 Illumina Product Information
4.2.3 Illumina Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.2.4 Illumina Targeted RNA Sequencing Business Performance
4.2.5 SWOT Analysis
4.3 Roche Holdings
4.3.1 Roche Holdings Profiles
4.3.2 Roche Holdings Product Information
4.3.3 Roche Holdings Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.3.4 Roche Holdings Targeted RNA Sequencing Business Performance
4.3.5 SWOT Analysis
4.4 BGI
4.4.1 BGI Profiles
4.4.2 BGI Product Information
4.4.3 BGI Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.4.4 BGI Targeted RNA Sequencing Business Performance
4.4.5 SWOT Analysis
4.5 Eurofins
4.5.1 Eurofins Profiles
4.5.2 Eurofins Product Information
4.5.3 Eurofins Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.5.4 Eurofins Targeted RNA Sequencing Business Performance
4.5.5 SWOT Analysis
4.6 LabCorp
4.6.1 LabCorp Profiles
4.6.2 LabCorp Product Information
4.6.3 LabCorp Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.6.4 LabCorp Targeted RNA Sequencing Business Performance
4.6.5 SWOT Analysis
4.7 Berry Genomics
4.7.1 Berry Genomics Profiles
4.7.2 Berry Genomics Product Information
4.7.3 Berry Genomics Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.7.4 Berry Genomics Targeted RNA Sequencing Business Performance
4.7.5 SWOT Analysis
4.8 Macrogen
4.8.1 Macrogen Profiles
4.8.2 Macrogen Product Information
4.8.3 Macrogen Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.8.4 Macrogen Targeted RNA Sequencing Business Performance
4.8.5 SWOT Analysis
4.9 GENEWIZ
4.9.1 GENEWIZ Profiles
4.9.2 GENEWIZ Product Information
4.9.3 GENEWIZ Targeted RNA Sequencing Production, Revenue, Price and Gross Margin
4.9.4 GENEWIZ Targeted RNA Sequencing Business Performance
4.9.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Targeted RNA Sequencing Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Targeted RNA Sequencing Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Targeted RNA Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Targeted RNA Sequencing Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Targeted RNA Sequencing Market Assessment by Regions
6.1 Global Targeted RNA Sequencing Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Targeted RNA Sequencing Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Targeted RNA Sequencing Price (USD/Unit) by Regions (2014-2020)
6.4 Global Targeted RNA Sequencing Gross Margin by Regions (2014-2020)
7 Targeted RNA Sequencing Regional Analysis
7.1 China Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.2 USA Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.6 India Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
7.8 South America Targeted RNA Sequencing Production, Revenue and Growth Rate (2014-2020)
8 Global Targeted RNA Sequencing Consumption Assessment
8.1 Global Targeted RNA Sequencing Consumption and Market Share by Regions (2014-2020)
8.2 Global Targeted RNA Sequencing Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Targeted RNA Sequencing Average Price (USD/Unit) by Regions (2014-2020)
9 Global Targeted RNA Sequencing Sales Assessment by Regions
9.1 Global Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.2 China Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.3 USA Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.4 Europe Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.5 Japan Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.6 Korea Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.7 India Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.8 Southeast Asia Targeted RNA Sequencing Sales and Sales Value (2014-2020)
9.9 South America Targeted RNA Sequencing Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Targeted RNA Sequencing Production and Revenue by Regions 2020-2026
12.1.2 China Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.7 India Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Targeted RNA Sequencing Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Targeted RNA Sequencing Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.3 China Targeted RNA Sequencing Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.8 India Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.2.10 South America Targeted RNA Sequencing Sales and Sales Value Forecast 2020-2026
12.3 Global Targeted RNA Sequencing Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Qualitative Targeted RNA Sequencing
12.3.3 Quantitative Targeted RNA Sequencing
12.4 Global Targeted RNA Sequencing Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Research Institutes
12.4.3 Hospitals & Clinics
12.4.4 Biotechnology Company
12.4.5 Others
12.5 Global Targeted RNA Sequencing Price and Gross Margin Forecast
13.5.1 Global Targeted RNA Sequencing Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Targeted RNA Sequencing Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
